PAR paradigm biopharmaceuticals limited..

Nice one...Good to see an increase in number of Biomarkers to be...

  1. 4,893 Posts.
    lightbulb Created with Sketch. 7607
    Nice one...
    Good to see an increase in number of Biomarkers to be observed, namely (but not necessarily limited to):

    • COMP
    • C terminal telopeptide (CTX) -II
    • NGF, interleukin (IL) -1ß,
    • TNFa,
    • IL-6
    • A disintegrin and metalloproteinase with thrombospondin motif 5 (ADAMTS-5),
    • ARGS (aggrecan cleavage fragments)
    • Tissue inhibitor matrix metalloproteinase 1 (TIMP-1)
    • CTX-I
    • Type II collagen (C2C)


    Quite a comprehensive study also looking at Pain, Function and Stiffness along with Serum samples.
    Will be illustrative to get a comparison between Synovium and Serum activity and the effects of iPPS on each.
    Last edited by Mozzarc: 12/02/21
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.0¢
Change
-0.035(7.53%)
Mkt cap ! $170.8M
Open High Low Value Volume
47.0¢ 47.5¢ 42.0¢ $676.1K 1.519M

Buyers (Bids)

No. Vol. Price($)
2 16161 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 19584 1
View Market Depth
Last trade - 16.10pm 07/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.